Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.24(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1675
+0.0023(+0.20%)
GBP/USD
1.2574
+0.0028(+0.22%)
Bitcoin GBP
51,182.74
+541.62(+1.07%)

Meet one of the UK’s largest unknown start-ups

Video editing platform Veed has grown to 10 million users

Biora Therapeutics, Inc. (BIOR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

0.7310

+0.0182

(+2.55%)

At close: 04:00PM EDT

0.7480

+0.02

(+2.33%)

After hours:

07:10PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	26.23M
Enterprise value	58.45M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	2.88k
Price/book (mrq)	N/A
Enterprise value/revenue	14.61k
Enterprise value/EBITDA	-0.51

Trading information

Stock price history

Beta (5Y monthly)	1.09
52-week change ³	-73.20%
S&P500 52-week change ³	22.38%
52-week high ³	6.7000
52-week low ³	0.5850
50-day moving average ³	0.9301
200-day moving average ³	1.7127

Share statistics

Avg vol (3-month) ³	462.96k
Avg vol (10-day) ³	221.85k
Shares outstanding ⁵	35.88M
Implied shares outstanding ⁶	35.88M
Float ⁸	13.75M
% held by insiders ¹	0.82%
% held by institutions ¹	61.29%
Shares short (15 Apr 2024) ⁴	1.4M
Short ratio (15 Apr 2024) ⁴	2.39
Short % of float (15 Apr 2024) ⁴	8.62%
Short % of shares outstanding (15 Apr 2024) ⁴	3.90%
Shares short (prior month 15 Mar 2024) ⁴	1.18M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:25
Last split date ³	03 Jan 2023

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-1,678,575.00%

Management effectiveness

Return on assets (ttm)	-99.04%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	4k
Revenue per share (ttm)	0.00
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-66.59M
Net income avi to common (ttm)	-124.33M
Diluted EPS (ttm)	-7.8800
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	15.21M
Total cash per share (mrq)	0.5
Total debt (mrq)	47.83M
Total debt/equity (mrq)	N/A
Current ratio (mrq)	0.30
Book value per share (mrq)	-3.64

Cash flow statement

Operating cash flow (ttm)	-48.5M
Levered free cash flow (ttm)	11.93M